The difference in disease progression between placebo and provenge was only 0.2 weeks favoring provenge so patients would likely be reintroduced to chemo and the total cost would be provenge + chemo. So it would appear that the total cost when treating a patient with provenge would be higher especially since the patient lives longer after disease progresses.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.